Globus Medical (GMED) Earnings Date, Estimates & Call Transcripts $62.82 +0.96 (+1.54%) As of 02:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Globus Medical Earnings Summary Globus Medical posted Q2 2025 earnings on August 7, 2025, reporting an EPS of $0.86, which beat the consensus estimate of $0.76 by $0.10. Quarterly revenue rose 18.4% year-over-year to $745.34 million, above analyst estimates of $738.91 million. With a trailing EPS of $2.60 and a P/E Ratio of 24.18, Globus Medical's earnings are expected to grow 17.15% next year, from $3.44 to $4.03 per share. Latest Q2 Earnings DateAug. 7EstimatedConsensus EPS (Aug. 7) $0.76 Actual EPS (Aug. 7) $0.86 Beat By $0.10 Actual Revenue (Aug. 7) $745.34MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get Globus Medical Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Globus Medical and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGMED Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GMED Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Globus Medical Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252$0.71$0.73$0.72Q2 20252$0.76$0.76$0.76$738.9 M$745.3 M - $745.3 MQ3 20252$0.78$0.87$0.83Q4 20252$0.92$0.97$0.95 FY 2025 8 $3.17 $3.33 $3.25 Q1 20262$0.79$0.81$0.80Q2 20262$0.93$0.93$0.93Q3 20262$0.99$0.99$0.99Q4 20262$0.84$1.08$0.96 FY 2026 8 $3.55 $3.81 $3.68 Q1 20271$0.84$0.84$0.84Q2 20271$1.07$1.07$1.07 Globus Medical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025$0.76$0.86+$0.10$1.50$738.91M$745.34M5/8/2025Q1 2025$0.74$0.68 -$0.06$0.54$629.74M$598.12M2/20/2025Q4 2024$0.74$0.84+$0.10$0.19$646.19M$657.29M11/5/2024Q3 2024$0.65$0.83+$0.18$1.28$604.69M$625.71M8/6/2024Q2 2024$0.68$0.75+$0.07$1.27$615.33M$629.69M5/7/2024Q1 2024$0.55$0.72+$0.17$1.49$586.82M$606.67M2/20/2024Q4 2023$0.59$0.60+$0.01$1.09$608.21M$616.53M11/7/2023Q3 2023$0.54$0.57+$0.03$1.13$306.78M$383.60M Globus Medical Earnings - Frequently Asked Questions When did Globus Medical announce their last quarterly earnings? Globus Medical (NYSE:GMED) last announced its quarterly earning data on Thursday, August 7, 2025. Learn more on GMED's earnings history. What guidance has Globus Medical issued on next quarter's earnings? Globus Medical issued an update on its FY 2025 earnings guidance on Monday, July, 21st. The company provided earnings per share guidance of 3.000-3.300 for the period, compared to the consensus estimate of 3.164. The company issued revenue guidance of $2.8 billion-$2.9 billion, compared to the consensus revenue estimate of $2.9 billion. Did Globus Medical beat their earnings estimates last quarter? In the previous quarter, Globus Medical (NYSE:GMED) reported $0.86 earnings per share (EPS) to beat the analysts' consensus estimate of $0.76 by $0.10. Learn more on analysts' earnings estimate vs. GMED's actual earnings. How can I listen to Globus Medical's earnings conference call? The conference call for Globus Medical's latest earnings report can be listened to online. Listen to Conference Call How can I read Globus Medical's conference call transcript? The conference call transcript for Globus Medical's latest earnings report can be read online. Read Transcript How much revenue does Globus Medical generate each year? Globus Medical (NYSE:GMED) has a recorded annual revenue of $2.63 billion. How much profit does Globus Medical generate each year? Globus Medical (NYSE:GMED) has a recorded net income of $102.98 million. GMED has generated $2.60 earnings per share over the last four quarters. What is Globus Medical's price-to-earnings ratio? Globus Medical (NYSE:GMED) has a trailing price-to-earnings ratio of 23.78 and a forward price-to-earnings ratio of 17.97. The price/earnings-to-growth ratio is 1.65. What is Globus Medical's EPS forecast for next year? Globus Medical's earnings are expected to grow from $3.44 per share to $4.03 per share in the next year, which is a 17.15% increase. More Earnings Resources from MarketBeat Related Companies STE Earnings Results PODD Earnings Results HOLX Earnings Results BAX Earnings Results MASI Earnings Results TFX Earnings Results ITGR Earnings Results ATEC Earnings Results ATRC Earnings Results IART Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals?Why SoundHound AI's Earnings Show the Stock Can Move HigherAirbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? This page (NYSE:GMED) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access